Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 5/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.75 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.75 |
| ▸ | AR | P10275 | 1/20 | 0.75 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.75 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.71 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.71 |
| ▸ | PPARG | P37231 | 1/20 | 0.71 |
| ▸ | PPARD | Q03181 | 1/20 | 0.71 |
| ▸ | PPARA | Q07869 | 1/20 | 0.71 |
| ▸ | XDH | P47989 | 1/20 | 0.61 |
| ▸ | CNR2 | P34972 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chavibetol SCHEMBL29752081 | 1.00 | ALOX5 (0.75) | ALOX5ALDH1A1CYP3A4PTGS1AR | |
| Chavibetol SCHEMBL6455963 | 0.91 | ALOX5 (0.63) | ALOX5ALDH1A1CYP3A4PTGS1AR | |
| Eugenol SCHEMBL28453397 | 0.86 | ALDH1A1 (0.93) | ALOX5ALDH1A1CYP3A4PTGS1AR | |
| Eugenol SCHEMBL28582775 | 0.86 | ALDH1A1 (0.93) | ALOX5ALDH1A1CYP3A4PTGS1AR | |
| Eugenol SCHEMBL788240 | 0.86 | ALDH1A1 (1.00) | ALOX5ALDH1A1CYP3A4PTGS1AR | |
| Eugenol SCHEMBL29126189 | 0.86 | ALDH1A1 (1.00) | ALOX5ALDH1A1CYP3A4PTGS1AR | |
| Eugenol SCHEMBL29364978 | 0.86 | ALDH1A1 (1.00) | ALOX5ALDH1A1CYP3A4PTGS1AR | |
| Eugenol SCHEMBL20361 | 0.86 | ALDH1A1 (1.00) | ALOX5ALDH1A1CYP3A4PTGS1AR | |
| SCHEMBL5659184 | 0.85 | XDH (0.66) | ALOX5ALDH1A1CYP3A4PTGS1AR | |
| Methyleugenol SCHEMBL5689919 | 0.85 | ALDH1A1 (0.90) | ALOX5ALDH1A1CYP3A4PTGS1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 450 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4655410-A2 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | Symrise AG (DE) | 2025-12-03 | — | — | EP | claimed |
| US-20250351832-A1 | PHYTOCHEMICALS AS BIOPESTICIDES AND BIOSTIMULANTS | KAY BEE BIO ORGANICS PVT LTD (IN) | 2025-11-20 | — | — | US | claimed |
| EP-4619472-A1 | MODIFIED PRECIPITATED SILICA, ITS MANUFACTURE AND USE | RHODIA OPERATIONS (FR) | 2025-09-24 | — | — | EP | claimed |
| CN-120059155-A | Polysiloxane polycarbonate, transparent flame-retardant scratch-resistant polycarbonate material, and preparation methods and applications thereof | 中国石油化工股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-120000698-A | Use of stevia extract | 上海维丘康敬生物科技有限公司 | 2025-05-16 | — | — | CN | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| CN-118592612-A | Health product containing stevia rebaudiana extract and application thereof | 上海维丘康敬生物科技有限公司 | 2024-09-06 | — | — | CN | claimed |
| WO-2024156879-A2 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | SYMRISE AG (DE) | 2024-08-02 | — | — | WO | claimed |
| US-20240228783-A1 | ASPHALT BINDERS WITH PHENOL-RICH OILS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2024-07-11 | — | — | US | claimed |
| CN-118160769-A | Basil essential oil preservation solution, preparation method thereof and application thereof in refrigeration preservation of snakehead slices | 上海海洋大学 | 2024-06-11 | — | — | CN | claimed |
| US-8748628-B2 | Process and composition of making polymerizable resins containing oxazolidone | DENTSPLY INTERNATIONAL INC. (US) | 2014-06-10 | — | — | US | claimed |
| US-20140100308-A1 | METHOD FOR PREPARING PHENOL-FORMALDEHYDE RESINS, RESIN MATERIALS AND METHOD FOR PREPARING RESIN MOLDING MATERIALS | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2014-04-10 | — | — | US | claimed |
| EP-2678366-A1 | PROCESS AND COMPOSITION OF MAKING POLYMERIZABLE RESINS CONTAINING OXAZOLIDONE | Dentsply International Inc. (US) | 2014-01-01 | — | — | EP | claimed |
| US-20130184467-A1 | PROCESS AND COMPOSITION OF MAKING POLYMERIZABLE RESINS CONTAINING OXAZOLIDONE | DENTSPLY INTERNATIONAL INC. (US) | 2013-07-18 | — | — | US | claimed |
| US-20130172451-A1 | METHOD FOR PREPARING PHENOL-FORMALDEHYDE RESINS, RESIN MATERIALS AND METHOD FOR PREPARING RESIN MOLDING MATERIALS | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-07-04 | — | — | US | claimed |
| WO-2012116268-A1 | PROCESS AND COMPOSITION OF MAKING POLYMERIZABLE RESINS CONTAINING OXAZOLIDONE | DENTSPLY INTERNATIONAL INC. (US) | 2012-08-30 | — | — | WO | claimed |
| US-20100254927-A1 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTER (US) | 2010-10-07 | — | — | US | claimed |
| WO-2009136408-A1 | SYNERGISTIC PHARMACEUTICAL COCRYSTALS | INSTITUTE OF LIFE SCIENCES (IN) | 2009-11-12 | — | — | WO | claimed |
| US-20050053678-A1 | Methods and compositions for betel nut chewing gum | HERBALSCIENCE NUTRACEUTICALS, INC. | 2005-03-10 | — | — | US | claimed |
| WO-2001006995-A1 | COSMETIC AGENTS CONTAINING HYDROXYCHAVICOL | COGNIS DEUTSCHLAND GMBH (DE) | 2001-02-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130184467-A1 | PROCESS AND COMPOSITION OF MAKING POLYMERIZABLE RESINS CONTAINING OXAZOLIDONE | OXA1L, DCXR, RPL27A | ALOX5 483/4885ALDH1A1 119/4885CYP3A4 242/4885 |
| US-20250351832-A1 | PHYTOCHEMICALS AS BIOPESTICIDES AND BIOSTIMULANTS | ACHE, DDT, BCHE | ALOX5 2551/4885ALDH1A1 928/4885CYP3A4 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.